Israel Englander’s Voyager Therapeutics VYGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $15.6M | Buy |
4,442,951
+1,014,380
| +30% | +$3.85M | 0.01% | 1864 |
|
|
2026
Q1 | $13.2M | Buy |
3,428,571
+1,547,811
| +82% | +$6.09M | 0.01% | 1908 |
|
|
2025
Q4 | $7.39M | Sell |
1,880,760
-411,943
| -18% | -$1.82M | ﹤0.01% | 2584 |
|
|
2025
Q3 | $10.7M | Buy |
2,292,703
+1,389,542
| +154% | +$5.03M | ﹤0.01% | 2325 |
|
|
2025
Q2 | $2.81M | Buy |
903,161
+804,679
| +817% | +$2.6M | ﹤0.01% | 3575 |
|
|
2025
Q1 | $333K | Buy |
98,482
+2,304
| +2% | +$10.8K | ﹤0.01% | 5043 |
|
|
2024
Q4 | $545K | Sell |
96,178
-60,935
| -39% | -$393K | ﹤0.01% | 4683 |
|
|
2024
Q3 | $919K | Buy |
+157,113
| New | +$1.14M | ﹤0.01% | 4346 |
|
|
2024
Q2 | – | Sell |
-100,725
| Closed | -$938K | – | 6604 |
|
|
2024
Q1 | $938K | Buy |
+100,725
| New | +$850K | ﹤0.01% | 4342 |
|
|
2023
Q4 | – | Sell |
-11,085
| Closed | -$85.9K | – | 6600 |
|
|
2023
Q3 | $85.9K | Sell |
11,085
-4,135
| -27% | -$37.8K | ﹤0.01% | 5376 |
|
|
2023
Q2 | $174K | Sell |
15,220
-1,147,333
| -99% | -$11.9M | ﹤0.01% | 5173 |
|
|
2023
Q1 | $8.96M | Buy |
1,162,553
+883,899
| +317% | +$7.03M | 0.01% | 2073 |
|
|
2022
Q4 | $1.7M | Sell |
278,654
-44,221
| -14% | -$251K | ﹤0.01% | 3702 |
|
|
2022
Q3 | $1.91M | Sell |
322,875
-505,921
| -61% | -$3.24M | ﹤0.01% | 3780 |
|
|
2022
Q2 | $4.9M | Buy |
828,796
+646,814
| +355% | +$4.37M | ﹤0.01% | 2833 |
|
|
2022
Q1 | $1.39M | Sell |
181,982
-241,076
| -57% | -$1.08M | ﹤0.01% | 4211 |
|
|
2021
Q4 | $1.15M | Buy |
423,058
+149,698
| +55% | +$511K | ﹤0.01% | 4280 |
|
|
2021
Q3 | $719K | Sell |
273,360
-244,502
| -47% | -$794K | ﹤0.01% | 4998 |
|
|
2021
Q2 | $2.14M | Buy |
+517,862
| New | +$2.35M | ﹤0.01% | 3880 |
|
|
2020
Q2 | – | Sell |
-222,298
| Closed | -$2.03M | – | 4641 |
|
|
2020
Q1 | $2.03M | Sell |
222,298
-270,365
| -55% | -$3.1M | ﹤0.01% | 2004 |
|
|
2019
Q4 | $6.87M | Buy |
+492,663
| New | +$7.16M | 0.01% | 1668 |
|
|
2019
Q3 | – | Sell |
-488,281
| Closed | -$13.3M | – | 4596 |
|
|
2019
Q2 | $13.3M | Buy |
488,281
+343,213
| +237% | +$7.85M | 0.02% | 1051 |
|
|
2019
Q1 | $2.78M | Sell |
145,068
-264,202
| -65% | -$3.44M | ﹤0.01% | 2191 |
|
|
2018
Q4 | $3.85M | Sell |
409,270
-58,346
| -12% | -$749K | 0.01% | 1760 |
|
|
2018
Q3 | $8.85M | Sell |
467,616
-152,302
| -25% | -$2.92M | 0.01% | 1403 |
|
|
2018
Q2 | $12.1M | Buy |
619,918
+1,897
| +0.3% | +$37.5K | 0.02% | 1191 |
|
|
2018
Q1 | $11.6M | Buy |
618,021
+342,148
| +124% | +$7.39M | 0.02% | 1246 |
|
|
2017
Q4 | $4.58M | Buy |
+275,873
| New | +$4.73M | 0.01% | 1779 |
|
Other funds holding VYGR
AC
VPC
OM
Israel Englander's VYGR Position: Q2 2026 in Review
Israel Englander increased its Voyager Therapeutics (VYGR) stake by 30% in Q2 2026, buying an estimated $3.85M and bringing the position to 4,442,951 shares worth $15.6M. The position accounts for 0.01% of the portfolio, ranked #1864.
Israel Englander first reported a position in VYGR in Q4 2017 and has held it in 28 quarters since. 135 funds tracked by Wall St. Rank hold VYGR as of Q2 2026.
- Israel Englander held 4,442,951 shares of Voyager Therapeutics worth $15.6M as of Q2 2026.
- Israel Englander bought 1,014,380 Voyager Therapeutics shares in Q2 2026, an estimated $3.85M.
- Voyager Therapeutics made up 0.01% of Israel Englander's portfolio in Q2 2026, its #1864 holding.
- Israel Englander first reported a position in Voyager Therapeutics in Q4 2017 and has held it in 28 quarters since.
- 135 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2026.
Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.